The proliferation response of circulating PD-1+ CD8+ T cells is more likely to be tumor-specific, as non-tumor-specific CD8+ T cells do not present an increase in the frequency of Ki-67+ cells after immunotherapy (36, 37). Here, CD8A is linked to neoplasm.